FDA Approves New Treatment for a Type of Late-stage Lung Cancer
The U.S. Food and Drug Administration has approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test.
Non-Small Cell Lung Cancer
Different types of treatments are available for people with non-small cell lung cancer. Surgery, radiation therapy, chemotherapy, targeted therapy, laser therapy, photodynamic therapy, cryosurgery, electrocautery, and watchful waiting are the nine standard treatments used for this cancer.
American Lung Association Resource Offers Lung Cancer Patients and Caregivers
The American Lung Association has launched Facing Lung Cancer: Support from Day One, a new patient- and caregiver-focused, web-based lung cancer information resource. This online tool offers interactive features that address specific topics of interest for people living with lung cancer and their loved ones.
Patient Advocate Foundation Receives Support to Aid Lung Cancer Survivors through Its Co-Pay Relief Program
The Patient Advocate Foundation has received a generous contribution that will allow the Foundation to continue to support people with non-squamous non-small cell lung cancer within its Co-Pay Relief Program. The program provides direct financial support for pharmaceutical co-payments to insured patients, including Medicare Part D beneficiaries, who financially and medically qualify, significantly reducing the financial burden associated with high medication costs.
Health and Prognosis Not Taken Into Account When Treating Older People with Lung Cancer
The study, published in the Journal of Clinical Oncology, found that treatment rates decreased more in association with advancing age than with the worsening of other illnesses. People between the ages of 65 and 74 who were severely ill from other illnesses, and thus less likely to benefit and more likely to be harmed from cancer treatment, received treatment at roughly the same rate as those in the same age range with no comorbidities.
Diagnosis: Lung Cancer
You have just been diagnosed with lung cancer. The first thing you must know, and something you should repeat to yourself over and over, is there is reason for hope! Much is being done for people with lung cancer, and new treatments are being developed and tested every day. Of course, you may experience many strong emotions – it is part of the process of dealing with your diagnosis. But a key part of living with lung cancer is to learn the facts, to stay positive, to be hopeful, and to remember that lung cancer can often be treated.
Highlights of the 2011 World Conference on Lung Cancer
The 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer (IASLC), was held in Amsterdam, Netherlands from 3 – 7 July 2011. The program drew together many lung cancer specialists from a wide range of disciplines from all over the world. More than 7,000 participants joined this unique scientific event.
Facing Lung Cancer
by Vladimir Lange, MD
“You have lung cancer.” These may be the most frightening words you’ve ever heard. You may feel scared, angry, crushed – or you may be in complete denial. The best approach you can take is to resolve, right now, that you will do everything you can to make sure your treatment is successful. So, where do you begin?